Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
Open | $7.950 |
Close | $7.530 |
Volume / Avg. | 245.982K / 342.661K |
Day Range | 7.510 - 8.170 |
52 Wk Range | 2.770 - 9.010 |
Market Cap | $212.822M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 7.67% |
Days to Cover | 4.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Other companies in Abeona Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), NuCana (NASDAQ:NCNA) and Design Therapeutics (NASDAQ:DSGN).
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 388.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $7.78 last updated April 17, 2024 at 9:30 AM EDT.
There are no upcoming dividends for Abeona Therapeutics.
Abeona Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Abeona Therapeutics.
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.